← All indications
Intracranial Hypertension
Increased pressure within the cranial vault. This may result from several conditions, including HYDROCEPHALUS; BRAIN EDEMA; intracranial masses; severe systemic HYPERTENSION; PSEUDOTUMOR CEREBRI; and other disorders.
Subtype terms (2)
More specific conditions that are subtypes of Intracranial Hypertension in the MeSH hierarchy.
- Hypertensive Encephalopathy
- Pseudotumor Cerebri
5 drugs (4 approved, 1 experimental)
Drugs by status
Phase 4 trials (5)
Phase 3 trials (2)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (15)
- National Eye Institute (NEI)
- Hospital Universitari Son Dureta
- Institut d'Anesthesiologie des Alpes Maritimes
- Institut National de la Santé Et de la Recherche Médicale, France
- Jaeb Center for Health Research
- St. Luke's-Roosevelt Hospital Center
- University of Iowa
- University of Rochester
- University of California, Davis
- University of Cincinnati
- Icahn School of Medicine at Mount Sinai
- Department of Defense
- Fondo de Investigacion Sanitaria
- Kalbe Farma TBK
- University of Franche-Comté
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (7)